Relmada outlines plans for NDV-01 Phase 2 results presentation and sepranolone development
Q4 2024 Management View CEO Sergio Traversa highlighted that Relmada is prioritizing progress on its product pipeline, particularly NDV-01 and Sepranolone, while also exploring product acquisition ...